Calliditas pushing on with kidney disease drug after IPO successCalliditas Therapeutics has just pulled off the largest biotech IPO in Europe this year and is using it Share XCalliditas pushing on with kidney disease drug after IPO successhttps://pharmaphorum.com/r-d/views-analysis-r-d/calliditas-pushing-kidney-disease-drug-ipo-success/
Boosting clinical trial productivity to prove Eroom wrongAccording to Eroom’s law, drug discovery becomes slower and costlier over time. And the data are, at least Share XBoosting clinical trial productivity to prove Eroom wronghttps://pharmaphorum.com/r-d/boosting-clinical-trial-productivity-to-prove-eroom-wrong/
The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?What can we learn from Batman and the Joker, the greatest hero/villain pairing of all time? Their co-dependent Share XThe art of storytelling in clinical data communication − what we can learn from Batman and the Joker?https://pharmaphorum.com/r-d/views-analysis-r-d/art-storytelling-clinical-data-communication/
Chinese pharma market primed for growth after sweeping reformsChina has carved itself a place as a major player in the pharma industry due to the number Share XChinese pharma market primed for growth after sweeping reformshttps://pharmaphorum.com/r-d/views-analysis-r-d/chinese-pharma-market/
Raising awareness about rare diseasesA family tragedy has prompted Kay Parkinson, founder of the rare disease charity Alstrom Syndrome UK, to create Share XRaising awareness about rare diseaseshttps://pharmaphorum.com/views-analysis-patients/awareness-rare-diseases/
Taking on the challenge of childhood epilepsyJapan’s Eisai has a long-term commitment to treating epilepsy, with a series of therapies already on the market Share XTaking on the challenge of childhood epilepsyhttps://pharmaphorum.com/r-d/views-analysis-r-d/taking-challenge-childhood-epilepsy/
Balancing the sySTEMA group of pharma companies – Amgen, AstraZeneca and GlaxoSmithKline – have partnered with the UK government’s Equalities Share XBalancing the sySTEMhttps://pharmaphorum.com/r-d/views-analysis-r-d/balancing-the-system/
When knowledge drives results: the impact of a winning data strategyHaving an effective clinical trial data strategy in place can make the difference between success and an expensive Share XWhen knowledge drives results: the impact of a winning data strategyhttps://pharmaphorum.com/r-d/views-analysis-r-d/when-knowledge-drives-results-the-impact-of-a-winning-data-strategy/
Communication problems holding back new cancer treatments Cancer immunotherapy is revolutionising oncology – but the Havas Lynx Group’s chief medical officer Vernon Bainton argues that the incredible progress is Share XCommunication problems holding back new cancer treatments https://pharmaphorum.com/oncology/communication-problems-holding-back-new-cancer-treatments/
